These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2220852)

  • 21. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 22. Indexing and abstracting services to the primary drug literature.
    Illsley SS; Sudds TW
    Hosp Formul; 1982 Sep; 17(9):1193-7. PubMed ID: 10257545
    [No Abstract]   [Full Text] [Related]  

  • 23. Residency programs in drug information.
    Kirkwood CF
    Am J Hosp Pharm; 1984 Jan; 41(1):145-6. PubMed ID: 6695931
    [No Abstract]   [Full Text] [Related]  

  • 24. Marketing drug information to corporations.
    Kimelblatt BJ; Kucich JM; Silverman HM; Simon GI
    Am J Hosp Pharm; 1982 Feb; 39(2):313-4. PubMed ID: 7058808
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality of drug information service provided by pharmaceutical manufacturers.
    Doyal LE
    Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug information residency rotation with pharmaceutical industry.
    Cramer RL
    Am J Pharm Educ; 1986; 50(2):154-6. PubMed ID: 10277398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disclosure of product information by manufacturers.
    Tse CS
    Am J Hosp Pharm; 1982 Apr; 39(4):645-6. PubMed ID: 7081244
    [No Abstract]   [Full Text] [Related]  

  • 28. Information responsibilities of generic drug companies.
    Cramer R
    Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
    [No Abstract]   [Full Text] [Related]  

  • 29. What drug information do doctors seek from hospital pharmacists?
    La Piana LJ
    Pharm Times; 1986 Apr; 52(4):74-6. PubMed ID: 10276473
    [No Abstract]   [Full Text] [Related]  

  • 30. Is drug advertising informing the consumer?
    Hanlon PM
    Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141
    [No Abstract]   [Full Text] [Related]  

  • 31. How to ask drug companies for help.
    Hayes JD
    Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
    [No Abstract]   [Full Text] [Related]  

  • 32. Computerized information systems used by the PMA.
    Cleveland CB; Marsh P
    Drug Inf J; 1975; 9(2-3):138-41. PubMed ID: 10297123
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug information resources for health professionals and consumers.
    Durkin C
    Natl Netw; 1998 Feb; 22(3):10-1. PubMed ID: 10176590
    [No Abstract]   [Full Text] [Related]  

  • 34. Hospital nurses' use of and satisfaction with sources of drug-related information.
    Wolfgang AP; Perri M; Kotzan JA
    Am J Hosp Pharm; 1989 Oct; 46(10):2052-3. PubMed ID: 2816961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Discouraging about drug therapy?].
    Reseland S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910-1. PubMed ID: 12830286
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA electronic drug labels to improve patient safety.
    J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical companies should offer reliable information, not freebies.
    Hulstrand EP
    Am J Hosp Pharm; 1989 Apr; 46(4):702. PubMed ID: 2719046
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical manufacturer's responses to drug information inquiries.
    Bainbridge CV; D'Ambrosio GG; Petrick RJ; Weiss EM
    Am J Hosp Pharm; 1982 Sep; 39(9):1532-4. PubMed ID: 7137196
    [No Abstract]   [Full Text] [Related]  

  • 39. Advantages and disadvantages of combining poison control and drug information centers.
    Troutman WG; Wanke LA
    Am J Hosp Pharm; 1983 Jul; 40(7):1219-22. PubMed ID: 6881165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.